Corrigendum to Cohort profile: The swiss inflammatory bowel disease cohort study (SIBDCS), [Int J Epidemiol, 2009; 38:922-931, 10.1093/ije/dyn180];Cohort profile: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)

International Journal of Epidemiology

Volumn 38, Issue 4, 2009, Pages 922-931

  Pittet, Valérie ^a   Juillerat, Pascal ^b,c   Mottet, Christian ^a,c   Felley, Christian ^b,c   Ballabeni, Pierluigi ^a   Burnand, Bernard ^a   Michetti, Pierre ^b,c   Vader, John Paul ^a   Mueller, Chistoph ^d   Rihs, Silvia ^d   Braegger, Christian ^e   Beglinger, Christoph ^f   Froehlich, Florian ^f   Vavricka, Stephan ^f   Seibold, Frank ^g   Schoepfer, Alain ^g   von Kaenel, Roland ^g   Begré, Stephan ^g   de Saussure, Philippe ^h   Meyenberger, Christa ⁱ   Sagmeister, Markus ⁱ   Rogler, Gerhard ^e   Kullak Ublick, Gerd A ^e   Meier, Remy ^j   Straumann, Alex ^k   Criblez, Dominique ^l   Engelmann, Matthias ^l   more..

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d Unilabs Mittelland   (Switzerland)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g UNIVERSITY OF BERN   (Switzerland)

^h UNIVERSITY OF GENEVA   (Switzerland)

ⁱ UNIVERSITY OF ST GALLEN   (Switzerland)

^j Kantonsspital Liestal   (Switzerland)

^k IBD Net   (Switzerland)

^l LUZERNER KANTONSSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; DISEASE PREVALENCE; DISEASE SPREAD; DISEASE TREATMENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ENTERITIS; EPIDEMIOLOGICAL DATA; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RESEARCH PRIORITY; RESEARCH SUBJECT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SWITZERLAND;

EID: 68949116316     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq078     Document Type: Erratum

References (40)

1. Baumgart DC, Carding SR. Inflammatory bowel disease: Cause and immunobiology. Lancet 2007;369:1627-40.
2. Rutgeerts P, Feagan BG, Lichtenstein GR et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004;126:402-13.
3. Rutgeerts P, Sandborn WJ, Feagan BG et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462-76.
4. Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: A single centre retrospective study. Gut 2004;53:1471-78.
5. Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics 2002;20:639-52.
6. Boonen A, Dagnelie PC, Feleus A et al. The impact of inflammatory bowel disease on labor force participation: Results of a population sampled case-control study. Inflamm Bowel Dis 2002;8:382-89.
7. Cohen RD. IBD indirect costs: The sleeping giant? Gastroenterology 2003;125:982-84.
8. Levenstein S, Prantera C, Varvo V et al. Stress and exacerbation in ulcerative colitis: A prospective study of patients enrolled in remission. Am J Gastroenterol 2000;95:1213-20.
9. Bitton A, Sewitch MJ, Peppercorn MA et al. Psychosocial determinants of relapse in ulcerative colitis: A longitudinal study. Am J Gastroenterol 2003;98:2203-8.
10. Bitton A, Dobkin P, Edwardes MD et al. Predicting relapse in Crohn's disease: A biopsychosocial model. Gut 2008, doi:10.1136/ gut.2007.134817.
11. Juillerat P, Pittet V, Bulliard J-L et al. Prevalence of inflammatory bowel disease in the Canton of Vaud (Switzerland): A population-based cohort study. J Crohn's Colitis 2008;2 131-41.
12. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114 1161-68.
13. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival. Gut 2000;46 336-43.
14. Loftus CG, Loftus EV Jr, Harmsen WS et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007;13 254-61.
15. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: A population-based study. Am J Epidemiol 1999;149:916-24.
16. Rubin GP, Hungin AP, Kelly PJ, Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000;14:1553-59.
17. Lapidus A. Crohn's disease in Stockholm County during 1990-2001: An epidemiological update. World J Gastroenterol 2006;12:75-81.
18. Daiss W, Scheurlen M, Malchow H. Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany). Scand J Gastroenterol Suppl 1989; 170:39-43.
19. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.
20. Firmann M, Mayor V, Vidal PM et al. The CoLaus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008;8:6.
21. Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study. Gastroenterology 2001;121 255-60.
22. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003; 124:1767-73.
23. Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull 1999;46:400-15.
24. Naylor CD. What is appropriate care? N Engl J Med 1998;338 1918-20.
25. Vader JP, Froehlich F, Juillerat P et al. Appropriate treatment for Crohn's disease: Methodology and summary results of a multidisciplinary international expert panel approach-EPACT. Digestion 2006;73:237-48.
26. Guessous I, Juillerat P, Pittet V et al. Evaluating appropriateness of treatment for Crohn's disease: Feasibility of an explicit approach. Digestion 2007; 75:46-52.
27. Polle SW, Slors JF, Weverling GJ, Gouma DJ, Hommes DW, Bemelman WA. Recurrence after segmental resection for colonic Crohn's disease. Br J Surg 2005; 92:1143-49.
28. Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalization in Crohn's disease. Am J Gastroenterol 2000;95 524-30.
29. Feagan BG, Vreeland MG, Larson LR, Bala MV. Annual cost of care for Crohn's disease: A payor perspective. Am J Gastroenterol 2000; 95:1955-60.
30. Lichtenstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005;128:862-69.
31. Aronowitz R, Spiro HM. The rise and fall of the psychosomatic hypothesis in ulcerative colitis. J Clin Gastroenterol 1988;10:298-305.
32. Levenstein S. Stress and ulcerative colitis: Convincing the doubting Thomases. Am J Gastroenterol 2003;98: 2112-15.
33. Ader R. On the development of psychoneuroimmunology. Eur J Pharmacol 2000;405:167-76.
34. von Kaenel R, Kudielka BM, Preckel D, Hanebuth D, Fischer JE. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav Immun 2006;20:40-48.
35. Kudielka BM, von KR, Preckel D, Zgraggen L, Mischler K, Fischer JE. Exhaustion is associated with reduced habituation of free cortisol responses to repeated acute psychosocial stress. Biol Psychol 2006;72:147-53.
36. Wusk B, Kullak-Ublick GA, Rammert C, von Eckardstein A, Fried M, Rentsch KM. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis. Eur J Gastroenterol Hepatol 2004;16:1407-13.
37. Wusk B, Kullak-Ublick GA, Rammert C, von Eckardstein A, Fried M, Rentsch KM. Thiopurine S-methyltransferase polymorphisms: Efficient screening method for patients considering taking thiopurine drugs. Eur J Clin Pharmacol 2004;60:5-10.
38. Newman B, Gu X, Wintle R et al. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology 2005;128:260-69.
39. Seibold F, Konrad A, Flogerzi B et al. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. Gastroenterology 2004;127:1076-84.
40. Sudre P, Rickenbach M, Taffe P, Janin P, Volkart AC, Francioli P. Clinical epidemiology and research on HIV infection in Switzerland: The Swiss HIV Cohort Study 1988-2000. Schweiz Med Wochenschr 2000; 130: 1493-500.